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In 1991, a group of expert scientists at a Wingspread work
session on endocrine-disrupting chemicals (EDCs) concluded that
‘‘Many compounds introduced into the environment by human
activity are capable of disrupting the endocrine system of animals,
including fish, wildlife, and humans. Endocrine disruption can be
profound because of the crucial role hormones play in controlling
development.’’ Since that time, there have been numerous
documented examples of adverse effects of EDCs in invertebrates,
fish, wildlife, domestic animals, and humans. Hormonal systems
can be disrupted by numerous different anthropogenic chemicals
including antiandrogens, androgens, estrogens, AhR agonists,
inhibitors of steroid hormone synthesis, antithyroid substances,
and retinoid agonists. In addition, pathways and targets for
endocrine disruption extend beyond the traditional estrogen/
androgen/thyroid receptor–mediated reproductive and developmental systems. For example, scientists have expressed concern
about the potential role of EDCs in increasing trends in early
puberty in girls, obesity and type II diabetes in the United States
and other populations. New concerns include complex endocrine
alterations induced by mixtures of chemicals, an issue broadened
due to the growing awareness that EDCs present in the
environment include a variety of potent human and veterinary
pharmaceutical products, personal care products, nutraceuticals
and phytosterols. In this review we (1) address what have we
learned about the effects of EDCs on fish, wildlife, and human
1
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health, (2) discuss representative animal studies on (anti)androgens, estrogens and 2,3,7,8-tetrachlorodibenzo-p-dioxin–like
chemicals, and (3) evaluate regulatory proposals being considered
for screening and testing these chemicals.
Key Words: endocrine disruptors; androgens; estrogens; dioxins;
PCBs; Pharmaceuticals; Mixtures; Screening and Multigenerational
Testing.

It has been approximately 15 years since the first World
Wildlife Federation (WWF) Wingspread Conference focused
on endocrine-disrupting chemicals (EDCs), and 10 years
since the U.S. Environmental Protection Agency (USEPA) was
given a mandate under the Food Quality Protection and Safe
Drinking Water Acts to develop test protocols to screen for
endocrine effects of chemicals. This review article will briefly
highlight some of the major scientific events that have taken
place since the inception of the EDCs issue. In this review, we will
(1) discuss EDCs effects on invertebrates, fish, wildlife, and human
health, (2) highlight some representative studies on (anti)androgens,
estrogens and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)–like
chemicals, and (3) evaluate regulatory proposals being considered
for screening and testing these chemicals.
An initial impetus for studies of EDCs arose from the
Wingspread work session in 1991 on ‘‘Chemically Induced
Alterations in Sexual Development: The Wildlife /Human
Connection’’ (Colborn and Clement, 1992). A consensus from
that meeting, reached by a panel of expert scientists was that
‘‘Many compounds introduced into the environment by human
activity are capable of disrupting the endocrine system of
animals, including fish, wildlife, and humans. Endocrine
disruption can be profound because of the crucial role
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hormones play in controlling development’’ (Colborn and
Clement, 1992). These scientists also ‘‘estimated with confidence’’ that developmental impairments in humans have
resulted from exposure to EDCs that are present in the
environment as a result of human activities. Within a 5-year
span several international organizations held meetings to discuss
the EDC issue and research objectives. For example, starting in
1996 the USEPA held a series of workshops highlighting the
new EDC issue and research needs in collaboration with the
WWF and Chemical Manufacturers Association (Ankley and
Giesy, 1998; Ankley et al., 1998; DeVito et al., 1999; Gray
et al., 1997a) The European Union (Weybridge Report,
European Commission,1996), Australia, and several Asian
countries including Korea, Japan held similar meetings.
Subsequent studies have strengthened the documentation of
effects of EDCs on animals. Although most of the effects in
humans are due to occupational exposures or pharmaceutical
usage, hundreds if not thousands of publications showing
associations between background EDC exposures and adverse
effects in humans are now available in the peer-reviewed
literature. Many of the associations between EDCs and human
health effects are controversial, but others, like the effects of
polychlorinated biphenyls (PCBs) on neurological and immune
function are quite widely accepted. Furthermore, animal laboratory studies corroborate many of these adverse effects
observed in the field and, in some cases, provide mechanisms
to explain the effects.
About 10 years ago the discussion of ‘‘endocrine disrupters’’
broadened from a focus on environmental estrogens to include
additional mechanisms of endocrine toxicity; mechanisms that
in many cases may be of equal or greater concern than
estrogens. Numerous ‘‘new’’ areas of interest and concern have
arisen since the original 1991 Wingspread conference and
regulatory mandates. These areas include processes potentially
disrupted by new classes of anthropogenic chemicals that act as
antiandrogens, androgens, inhibitors of steroid hormone
synthesis, antithyroid substances, and retinoid agonists. Within
the last few years, scientists also have expressed concern about
the potential role of EDCs in increasing trends in obesity and
type II diabetes in the United States and other populations. In
addition, although research has documented the complexity of
the multiple mechanisms by which a single chemical can alter
the endocrine milieu, recent evidence demonstrates the need to
investigate complex endocrine alterations induced by mixtures
of chemicals. We are now not only concerned about pesticides
and other toxic substances in the environment, but the issue has
broadened considerably due to the growing awareness that the
list of EDCs present in the environment from human activities
includes potent human and veterinary pharmaceutical products,
personal care products, nutraceuticals and phytosterols. Among
the drugs found as pharmaceuticals in the environment (PiEs)
are potent, long lasting estrogens, antibiotics, b-blockers,
antiepileptics, androgenic steroids, and lipid regulating agents.
Some PiEs have been linked to dramatic effects in wildlife,

including death in bald eagles (http://www.fws.gov/southeast/
news/2002/12-03SecPoisoningFactSheet.pdf), threatened extinction of species of vultures in Asia (Shultz et al., 2004)
and sex reversal and infertility in several species of fish (WHO,
2002.).
The 1996 legislation mandated that the USEPA both
establish validated screening and testing procedures for
estrogens and other substances as deemed appropriate and
consider combinations of chemicals rather than evaluate the
potential risk on a chemical by chemical basis. Both of these
mandates encompass new areas of investigation in the EDC
field. Furthermore, reports of nonmonotonic (e.g., U-shaped)
dose–response relationships, ultra-low dose effects and nonthreshold effects for EDCs continue to challenge some of the
basic assumptions of toxicology and risk assessment. Although
the focus of this debate has centered on the low dose effects of
Bisphenol A, U-shaped dose–response curves are well known
from many in vitro and a few in vivo studies. It appears that the
basic tenet of toxicology from Ames and Gold (2000) that
‘‘dose alone determines the poison’’ is too limited for some
EDCs because the timing of exposure can dictate not only the
effect, but also whether the effects are adverse versus
beneficial, or permanent versus transient. In vivo, however,
the U-shaped effects of EDCs are generally limited to one or
two effects whereas all other effects display ‘‘normal’’ nonmonotonic dose responses. Furthermore, EDCs that induce
cellular and molecular alterations of endocrine function at low
dosage levels produce a cascade of effects increasing in severity
resulting in adverse alterations at higher doses. The effects in the
high dose groups may be different from those seen at low doses
and the low dose effects are often causally linked to the high
dose adverse effects of the chemical. This is true for androgens,
natural estrogens, xenoestrogens, and antiandrogens.
The present review will focus on some of the new scientific
issues in regard to EDCs that have surfaced since the initial
Wingspread conference. The review will focus on effects of
endocrine-active chemicals on the androgen, estrogen, and
AhR-mediated signaling pathways. Reviews of other hormonal
pathways potentially affected by EDCs, such as the thyroid
system, can be found elsewhere (Guillette, 2006; Howdeshell,
2002; Tabb and Blumberg, 2006; Zoeller and Crofton, 2005).

EDC EFFECTS ON FISH AND WILDLIFE, DOMESTIC
ANIMALS, AND HUMAN HEALTH

Invertebrates, Fish, and Wildlife
Endocrine-disrupting compounds have had dramatic effects
on some invertebrate, fish, and wildlife populations. The
diversity in life histories and habitats of animals in the
environment introduce the possibility of species or life-stage–
specific responses to EDCs that may not be evident in
controlled laboratory experiments. Chemicals including
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organotins, organochlorine pesticides, PCBs, and steroidal
androgens and estrogens have all been associated with
endocrine-mediated dysfunction in fish and wildlife populations. Wildlife studies can identify emerging contaminant
problems, as well as inform about mechanisms of toxicity from
laboratory work.
Great strides have been made in establishing cause and effect
linkages between EDC exposures and observed effects in
wildlife despite the inherent challenges. The complexity of
environmental exposures often precludes identification of
a single chemical responsible for observed population level
effects. Additionally, it can be difficult to identify the
underlying mechanism of the effect. These obstacles can be
overcome by using a weight-of-evidence approach to assess the
entire body of work surrounding observed wildlife effects.
Criteria have been developed for assessing the strength of
the causal linkage between contaminant exposure and population level effect (Ankley et al., 1998; WHO, 2002). These
criteria assess the cause–effect connection based on concepts of
temporality, strength of association, consistency of observation, biological plausibility, and evidence of recovery (WHO,
2002). There are several cases where strong evidence supports
a causal linkage between exposure and effect (Table 1). Two
examples discussed in detail below are organotin-mediated
imposex in marine snails and feminization of sewage effluentexposed male fish.
Exposure to the biocide tributyltin (TBT) causes imposex, or
pseudohermaphroditism in female prosobranch gastropods (for
reviews see, Ankley and Giesy, 1998; WHO, 2002). Imposex is
the imposition of male sex organs, including penis and vas
deferens, onto female snails and can lead to reproductive
failure in some species (Horiguchi, 2006). It has been
documented worldwide in around 150 species (Horiguchi,
2006). Due to these effects, use of TBT was restricted during
the 1990#s leading to subsequent recovery in multiple marine
snail populations (Jorundsdottir et al., 2005). High levels of
TBT, however, are still found in some aquatic ecosystems
because all usages have not been banned. The observation of
imposex in these organisms has been associated in some
studies with increased titers of testosterone in snail tissue
(Spooner et al., 1991). Although there are several competing
hypotheses for this effect, including aromatase inhibition,
altered metabolism of testosterone, and disruption of neuropeptide signaling; a definitive mechanism of action has yet to
be fully confirmed (Horiguchi, 2006; Sternberg et al., 2008).
New studies indicate that TBT causes imposex in invertebrates
by acting as a retinoid X receptor (RXR) agonist, and displays
an affinity for both invertebrate and vertebrate retinoid
receptors (Nishikawa et al., 2004).
Exposure to sewage effluent has been associated with
induction of vitellogenin in male fish and the occurrence of
intersex in wild fish (Jobling et al., 2002a, b). Vitellogenin is
an estrogen-responsive egg yolk protein precursor not normally
expressed in male fish. A gradient of effect exists with fish
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closest to the sewage outflow demonstrating the most severe
responses (Harries et al., 1999). Initial attention on feminized
fish focused primarily on studies from the United Kingdom,
however, the phenomenon seems to be relatively global in
nature (Ankley et al., 2007; WHO, 2002). For example, in the
United States, the Potomac River has been identified as a hot
spot for feminized smallmouth bass (Chambers and Leiker,
2006).
Caged fish and laboratory-based exposures confirm that
sewage effluent is responsible for the observed increases in
vitellogenin (WHO, 2002) and reproductive failure (Martinovic
et al., 2007). Although no single chemical has been identified
as the culprit, chemical fractionation studies of sewage effluent
have shown that synthetic and natural estrogens are often
present in biologically relevant quantities (Desbrow et al.,
1998; WHO, 2002). These estrogenic compounds include
synthetic pharmaceuticals and natural hormones in wastewater,
such as ethinyl estradiol and 17b-estradiol. Various laboratory
studies have shown that exposure to relatively low levels of
these steroids will induce vitellogenin and can cause the
development of intersex gonads (ovotestis) in fish and
amphibians (Hutchinson et al., 2006). Furthermore, a recent
study by Kidd et al. (2007) showed that levels of ethinyl
estradiol sufficient to cause vitellogenin induction in fish also
caused a substantial decrease in the sustainability of the wild
fish populations.
In some instances, there is moderate evidence for a causal
linkage between EDC exposure and effects in wildlife; for
example, PCB-induced reproductive and immune dysfunction
in Baltic seals (Table 1). Great Lakes trout populations were
adversely affected by PCB and dioxin exposures in the 1960–
1970#s, PCB-exposed cormorants displayed crossed-bills, great
blue herons were infertile, and mink fed PCB contaminated fish
from the Great Lakes either died after high exposures or were
infertile at lower exposure levels. Proposed associations, which
remain weak and also require elucidation, include reproductive
and developmental anomalies in frogs exposed to atrazine and
cryptorchidism in Florida panthers (Table 1).

Domestic Animals
Naturally occurring compounds with estrogenic and other
endocrine activities are widespread in nature. Over 400 species
of plants contain known estrogens such as isoflavonoids or
coumestans, or are suspected of being estrogenic based on
biological grounds. Plants also may contain other compounds,
in addition to estrogens, that can affect reproductive performance, such as antiandrogens in oil from saw palmetto (Gray
et al., 2001a).
Some plant estrogens occur at sufficient concentrations to
cause reproductive alterations in domestic animals. ‘‘Clover
disease,’’ which is characterized by dystocia, prolapse of the
uterus and infertility, is observed in sheep grazed on clover
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TABLE 1
Field and Lab Criteria for Determining a Causal Linkage between Endocrine Disruptors and Wildlife Effects (Ankley and Giesy, 1998; Gray et al., 1998; WHO, 2002)

Animal

Notable
effect

Fish
Fish

Feminization
Masculinization

Lake Trout

Low hatchability
of fertilized eggs
Reproductive failure
Reproductive failure
Immune dysfunction
Demasculinization

Mink/otter
Seals
Seals
Alligator

Frogs

Hermaphroditism/
Demasculinization
Polar bears
Demasculinization
Florida panthers Cryptorchidism

TBT
p,p#-1,1-Dichloro-2,2-bis
(p-chlorophenyl)
ethylene (DDE)
Sewage effluent
Pulp/paper mill
effluent
TCDD-like
compounds
PCBs
PCBs
PCBs
p,p#-DDE and other
organochlorine
pesticides
Atrazine
PCBs
Agricultural
chemicals

Lab criteria

Correlation
Specific effect(s) Exposure Correlation of decrease
Effect involved observed in
correlates
of effect in effect with
Exposure–effect in multiple
exposed
with effect with exposure exposure
correlation
populations
population
onset
overtime
remediation

Replication
of field effects
Replication
in lab species Identification of effect with
with relevant of mechanism like-acting
concentrations of action
chemicals

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ

þ

þ

þ
þ
þ
þ

þ
þ
þ
þ

þ
þ
þ
þ

þ/

þ

þ

þ

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ/
þ/

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ
þ

þ

þ

þ

þ

þ/

þ

þ
þ
þ

þ
þ
þ

þ

þ
þ
þ
þ/

þ/
þ/
þ/

þ

Note. þ indicates that data support the listed criteria; þ/ indicate that some data support the listed criteria, but more work is needed to confirm.

þ
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Marine snails Imposex
Predatory birds Egg shell thinning

Chemical(s)

Field criteria

ENVIRONMENTAL ENDOCRINE DISRUPTERS AND HUMAN AND WILDLIFE HEALTH

containing potent plant estrogens. Permanent infertility can be
produced in ewes by much lower amounts of estrogen over
a longer time period than are needed to produce clover disease
(Adams, 1995).
In domestic animals, feeds contaminated with the zearalenone-producing fungus (Fusarium spp.) induce adverse reproductive effects in a wide variety of domestic animals,
including impaired fertility in cows and hyperestrogenism in
swine (Meyer et al., 2000) and turkeys (Gray et al., 2001a).
Humans
Several chemicals are known to directly affect the endocrine
system by altering development or reproduction in humans.
Although other chemicals affect the reproductive system and
indirectly alter endocrine function resulting in endocrine
disruption and disruption of other components of the reproductive system. The examples of anthropogenic chemicals
known to interact with the human endocrine system discussed
herein includes accidental exposures to pesticides, toxic
substances and pharmaceuticals with adverse side effects. In
addition, we also discuss a few cases where pesticides or their
metabolites and plant derived chemicals have been found to
possess sufficient endocrine activity to be considered for use as
pharmaceuticals, although no adverse effects have been
associated with use of these chemicals. Some of the chemicals
discussed are hormone agonists or antagonists or directly alter
hormone synthesis. Others affect multiple cell types in the
reproductive system including those like the Sertoli cell, cells
that have both endocrine (secretes several hormones including
antimullerian hormone and inhibin) and nonendocrine functions (support germ cell development).
Reproductive Effects of Chemicals in Humans Resulting
from Occupational or Accidental Exposures or
Pharmacological Side Effects
Accidental, occupational and therapeutic exposures to EDCs
have produced adverse effects in humans (e.g., effects seen
with PCBs (AhR and non-AhR pathways), TCDD,
2-bromopropane (likely affects the endocrine system indirectly), 4,4#-diaminostilbene-2,2# disulfonic acid (DAS) (possible estrogenic mechanism), diethylstilbestrol (DES, estrogenic
mechanism), the androgenic drugs danazol and methyltestosterone, and aminoglutethimide (drug that was taken that
inhibits aromatase directly) (reviewed in Gray et al., 2001a, b).
Developmental Reproductive Toxicants Acting via an
Endocrine Mechanism
In Utero
In a very well-documented example of EDC effects in
humans, in utero exposure to the estrogenic chemical DES
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alters reproductive development. Specifically, DES taken
during pregnancy to prevent premature birth, which it failed
to do, caused developmental alterations in the daughters
including clear cell adenocarcinoma of the vagina, and gross
structural abnormalities of the cervix, uterus, and fallopian
tube. Women who were exposed to DES in utero are more
likely to have spontaneous abortions, ectopic pregnancies and
premature births (Steinberger and Lloyd, 1985). Developmental DES exposure has been reported to cause women to
have less well-established sex-partner relationships; reduced
sexual desire, excitability, and coital functioning, and an
increased masculine pattern of cerebral lateralization on
a verbal task (reviewed by Gray et al., 2001a). Although far
less prevalent and certain (Joffe, 2003), there are reports that
males are also affected by developmental exposure to DES,
displaying underdevelopment or absence of the vas deferens,
epididymis, and seminal vesicles and persistence of the
Mullerian ducts (Steinberger and Lloyd, 1985). They also
reported that DES causes epididymal cysts, hypotrophic
testes and infertility, and, in some males reduced ejaculate
volume and numbers of motile sperm (Steinberger and Lloyd,
1985).
In utero exposure to the androgenic drug, danazol, also is
contraindicated during pregnancy. Brunskill (1992) reported
that of 94 completed pregnancies, 37 resulted in the birth of
normal males, 34 in nonvirilized females, and 23 in virilized
females. Virilization occurred in a proportion of female fetuses
with a pattern of clitoromegaly, fused labia and urogenital sinus
formation. The abnormality has not been reported where
danazol therapy had been discontinued before the eighth week
of pregnancy. Although more common in the higher dosages,
virilization was reported in one case with a 200 mg daily
dosage. Similar effects have been reported for other androgenic
drugs (Grumbach and Ducharme, 1960; Saunders, 1968). The
anticonvulsant drug aminoglutethimide, which inhibits aromatase and the production of estrogens from androgens, has also
been associated with pseudohermaphroiditism in daughters
(LeMaire et al., 1972).
Pubertal
In another more recent example of unintended effects of
EDCs in humans, estrogen-containing shampoos (Tiwary,
1998) and skin oils (Henley et al., 2007) were shown to be
causative factors for pseudoprecocious puberty in girls and
gynecomastia in boys (Felner and White, 2000). Some of the
shampoos, for example, contained up to 4 mg of estradiol per
100 g. Others contained up to 2 g of the much less potent
estriol per 100 g (Tiwary, 1998).
Virilization in young children as young as 17 months of age
is uncommon and is produced by androgens (Kunz et al.,
2004), which may be from endogenous or exogenous sources.
Recently, the increased availability and use of commercial
androgen products for cutaneous application has increased the
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risk of virilization in children through skin contact and passive
absorption.

normal. He proposed that mitotane was cytotoxic to the testis
as it is to the adrenal cortex.

Reproductive Toxicity in Adults Resulting from an
Endocrine Mechanism

Reproductive Toxicity in Adults that Indirectly Produces
Endocrine Alterations

Clinical studies by The National Institute of Occupation
Safety and Health documented sexual impotence in chemical
factory workers exposed to DAS, a DES-like stilbene derivative. These studies were carried out in response to
complaints of impotence and decreased libido among male
workers involved in the manufacture of DAS, a key ingredient
in the synthesis of dyes and fluorescent whitening agents. The
data from the studies showed that workers manufacturing DAS
had lower serum testosterone levels and reduced libido
(Grajewski et al., 1996; Whelan et al., 1996) as compared
with control workers. They found that ‘‘Current and former
DAS workers had lower mean total testosterone (TT) levels
compared with additives workers (458 and 442, respectively,
vs. 556 ng/dl; p ¼ 0.05 and 0.04). Current and former DAS
workers were 3.6 (95% CI, 0.5–24.4) and 2.2 (95% CI, 0.3–
18.0) times more likely than additives workers to have lowest
quartile TT levels (< 386 ng/dl) after adjustment for age and
body mass index. Duration of employment in DAS production
was negatively related to the workers’ testosterone levels.’’
Studies in rodents suggest that DAS has estrogenic activity,
possibly providing a possible mechanistic explanation for the
complaints of impotency in factory workers exposed to these
substances (Smith and Quinn, 1992).
The o,p#-dichlorodiphenyltrichloroethane (DDT) metabolite,
o,p#-Ortho,para,dichlorodiphenyl dichloroethane (DDD) has
historically been considered as an environmental contaminant.
However, o,p#-DDD also has clinical uses due to its ability to
alter endocrine function and it has been reported to induce both
beneficial and adverse side effects. o,p#-DDD (Mitotane), has
been used to treat adrenal steroid hypersecretion associated
with adrenal tumors in humans and pets (Reine, 2007). It has
been reported to act by inhibiting P450 steroidogenic enzymes
and also has some estrogenic activity in humans (Nader et al.,
2006). In addition, mitotane treatment restored menstruation in
women with high androgen levels of spanomenorrhea
associated with hypertrichosis with pregnancies occurring in
about a third of the treated women (Hayes and Laws, 1991).
However, Mitotane treatment has been associated with atrophy
of the spermatogenic tubules of the testis in men (Sparagana,
1987). Sparangana studied a patient who developed impotency
due to primary testicular failure at the time that he was treated
with Mitotane. A testicular biopsy, performed after the drug
was discontinued, showed normal appearing Leydig cells and
atrophy of the seminiferous tubules with the picture of
a maturation arrest. In the four and one half years since he
last received mitotane, the patient’s libido has slowly improved
and his plasma testosterone, gonadotropins and LH response to
gonadotropin-releasing hormone have become essentially

Yet another example of a chemical altering reproductive and
endocrine function in humans is 2-bromopropane (CERHR,
NTP, 2003) (Kim et al., 1996). Korean electric workers
exposed to solvents containing this chemical displayed
reproductive and endocrine abnormalities. Specifically, women
showed secondary amenorrhea, primary ovarian failure with
high follicle–stimulating hormone levels, hot flashes and
undetectable estradiol levels (below 13.6 pg/ml the LOD).
Exposed men displayed azoospermia, some degree of oligospermia, or reduced sperm motility (Kim et al., 1996) but had
normal libido and based upon hormonal levels it appears that
the germ cells and not the Leydig cells were directly affected
by 2-bromopropane (2003).
Dibromochloropropane (DBCP) is another human reproductive toxicant that indirectly disrupts endocrine function in
humans (Lag et al., 1989; Potashnik and Porath, 1995;
Potashnik and Yanai-Inbar, 1987; Slutsky et al., 1999;
Whorton and Foliart, 1983; Whorton and Milby, 1980;
Whorton et al., 1979). The pesticide DBCP acts directly on
the germ cells as a mutagen. Occupational exposures during
manufacturing and application in several countries (Teitelbaum,
1999) resulted in permanent oligospermia, azoospermia, and
infertility, and indirectly elevated FSH levels and nonsignificant reductions in testosterone. Unlike 2-bromopropane,
above, few women were exposed to DBCP. In rodents, in utero
DBCP severely disrupts fetal testis development (Warren et al.,
1988). Effects on sperm counts and FSH levels persist in
some workers for at least 17 years. Despite the ban on the
use of DBCP, this pesticide remains persistent in soil and
continues to be detected as a groundwater contaminant in
areas of past high use, in particular California’s Central Valley
(Clark and Snedeker, 2005; Teitelbaum, 1999). Although
case–control, cohort and ecological epidemiology studies
have not found significant, positive associations between
DBCP exposure and cancer in exposed populations, concerns
persist due to the cited limitations in these studies (Clark and
Snedeker, 2005).
EDCs in Humans and Effects at Background Exposure
Levels
In contrast to the above examples, background human EDC
exposure–effect relationships have only occasionally
approached a significant degree of certainty. There are literally
thousands of studies on the potential effects of EDCs on human
health. Although many of the have shown associations among
EDC and reproductive alterations (sperm abnormalities,
shortened anogenital distance in boys, altered sex ratio, testis
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cancer, cryptorchidism, hypospadias, testes cancer, prostate
cancer, advanced onset of puberty, breast cancer, endometriosis, obesity, attention deficit disorder, uterine cancer, and
allergies) many others have failed to find such associations and,
for this reason, there remains a great deal of uncertainty about
the effects of background levels of EDCs on human
reproduction. Although it is very important that scientists
continue to evaluate the effects of background levels of EDCs
on human disease, it is more important to prevent as opposed to
detect the effects of EDCs on humans, fish, and wildlife. As
stated by Lucier (2007; http://domesticpolicy.oversight.house.
gov/documents/20070925143750.pdf), ‘‘We should keep in
mind that a positive finding in an epidemiology or clinical
study is, in reality, a failure of preventive medicine policy.’’
In contrast, the effects of the PCBs on human neurological
and immune development, is one case where many scientists
have concluded that the data are robust enough to conclude that
they approach the level of cause and effect (reviewed in
Brouwer et al., 1999; Selgrade, 2007). Even here, there
remains considerable uncertainty. In contrast to background
levels of PCBs, children accidentally exposed to high levels of
PCBs and dibenzofurans display neurobehavioral abnormalities from exposure in utero and during early postnatal
development (Guo et al., 1995). These changes included low
birth weight, malformations, and reduced IQ and cognitive
abilities. Furthermore, the exposed males exhibited abnormal
sperm morphology, reduced sperm motility, and reduced in
vitro sperm fertilizing capacity (Guo et al., 1995). Selgrade
(2007) recently concluded that ‘‘suppression of immune
responses in rodents is predictive of suppression of immune
responses in humans and that there is a relationship between
immune suppression following developmental exposure to the
toxicants and enhanced risk of infectious or neoplastic disease
in humans’’ for PCBs as well as cigarette smoke and arsenic.
Adverse Effects of EDCs in Laboratory Animals
In Vivo Studies on Select Classes of EDCs
The following section briefly reviews selected examples of
the effects of EDCs on, mostly, rodent reproductive development. Although this review does not include a discussion
of the in vitro and short-term studies examining the mode(s) of
action of the selected chemicals, such studies are essential to
confirm mechanisms of action hypothesized from in vivo
studies. Specific EDC classes considered here include antiandrogens, androgens, estrogens and AhR agonists (such as
TCDD).
Environmental antiandrogens. Several environmental
chemicals adversely affect male development by interfering
with androgen signaling during the critical periods of sexual
differentiation and maturation. Depending on the timing of
exposure (e.g., in utero or peripubertal), these antiandrogens
affect androgen-sensitive organs and processes within the male
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rat, leading to histological lesions within the reproductive
organs, delayed puberty (Monosson et al., 1999), hypospadias/
cryptorchidism, reduced fertility, and testicular tumors. Mechanistic work has identified some antiandrogenic chemicals to
be androgen receptor (AR) antagonists, e.g., the DDT
metabolite p,p#-DDE (Kelce et al., 1995), the fungicides
vinclozolin (Gray et al., 1994; Kelce et al., 1997), procymidone (Gray et al., 2006; Hosokawa et al., 1993; Ostby et al.,
1999) and prochloraz, the herbicide linuron, and polybrominated diphenyl ether (PBDE) flame retardants (Stoker et al.,
2005).
Some chemicals can produce antiandrogenic effects via
depression of testicular testosterone production. The fungicide
prochloraz induces malformations in male offspring and delays
the onset of puberty after peripubertal exposure, with
mechanistic work revealing that it is not only an AR antagonist
but also acts as a potent steroid synthesis inhibitor (Blystone
et al., 2007a, b; Noriega et al., 2005; Wilson et al., 2004c).
Similarly, linuron, is both an AR antagonist (Lambright et al.,
2000) and it reduces testosterone production (Hotchkiss et al.,
2004; Wilson et al., 2004c). The AR antagonism and reduced testosterone production displayed by these chemicals
(Hotchkiss et al., 2004; Wilson et al., 2004c) likely has a
cumulative effect on the male offspring, but the relative contribution of each mechanism requires further clarification.
Several phthalate esters, used as plasticizers in many
commercial products, are antiandrogens, which gives cause
for concern because there is widespread exposure to these
chemicals (Silva et al., 2004). Malformations of male
reproductive organs occur after in utero exposure to some
phthalates (e.g., dibutyl phthalate, butyl benzyl phthalate,
DEHP, di-iso-nonyl phthalate) and, through a mechanism that
has yet to be established, these chemicals reduce fetal rat
testosterone production (Foster, 2006; Gray et al., 2000;
Mylchreest et al., 1998; Parks et al., 2000; Sharpe, 2006;
Wilson et al., 2004c). In addition to reduced testosterone,
phthalate exposure also reduces insl-3 gene expression (Wilson
et al., 2004c); the insl-3 peptide hormone is necessary for
transabdominal testis decent (Klonisch et al., 2004).
The spectrum of malformations that result from disrupting
the androgen signaling pathway varies depending on the
mechanism of action. For example, hypospadias is prominent
at high doses of vinclozolin (whose metabolites are AR
antagonists), whereas high levels of phthalates (which reduce
fetal testosterone and insl-3 expression) induce epididymal
agenesis. However, linuron and prochloraz, two chemicals that
one would expect to display similar effects based upon similar
dual mechanisms, differ in the relative rates of hypospadias and
epididymal agenesis that they induce (Gray et al., 2006).
Together this area of EDC research has characterized the
effects of several antiandrogens and identified relevant and
diverse mechanisms of action pertinent to human health risk
assessment because this pathway is highly conserved among
vertebrates. Disruptions of this pathway either via genetic
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mutations or steroid-like chemical exposures results in profound examples of pseudohermaphroditism in experimental
animals and humans (Quigley et al., 1995).
The reproductive system is also sensitive to phthalate
exposure during the peripubertal and neonatal stages of life.
Rats treated with diethyl hexyl phthalate (DEHP) orally or by
injection as neonates display permanent alterations lesions of
the testis and sperm numbers (Cammack et al., 2003; Dostal
et al., 1988). When administered during peripubertal life, din-phthalate esters with side chains with three to six carbons
(Foster et al., 1981) disrupt testis structure and function,
reduces testosterone production, delays pubertal onset and
reduces androgen-dependent organ weights in male rats (Gray
et al., 1999). These effects are not limited to Murid and
Cricetid rodents like the rat and hamster, respectively, and have
been seen in several other mammalian species including the
guinea pig (Gray et al., 1982), ferret (Lake et al., 1976) and
rabbit (Higuchi et al., 2003).
Sjoberg et al. (1986) found an age sensitivity in response
with the adults more resistant to testicular damage than pubertal
animals. When he administered DEHP in the diets of 25-, 40-,
and 60-day-old male rats for 14 days, testis weight was reduced
in males in 25-day-old males (at 1 g/kg/day) and 40 (at 1.7 g/
kg/day) and all testis tubules were damaged in 25-day-old
males (at 1.7 g/kg/day). No testicular effects were observed in
60-day-old animals (Sjoberg et al., 1986).
Environmental androgens. It was noted in the 1970#s that
female fish of several species living in rivers contaminated with
pulp mill effluent (PME) displayed masculinized sexual traits
and starting in 2001 two different research teams reported that
PME displayed androgenic activity in in vitro assays (Jenkins
et al., 2003; Parks et al., 2001). Since then, androgenic activity
has been detected in PME from other rivers in Florida, the
Baltic Sea, the Great Lakes and New Zealand (Ellis et al.,
2003; Larsson and Forlin, 2002; Parks et al., 2001). PME
effluents from sites on the Fenholloway River in Florida
include a chemical mixture that binds AR and induces
androgen-dependent gene expression in vitro. This mode of
action is consistent with the observation of masculinized
female mosquitofish (Gambusia holbrooki) collected from
contaminated sites on the river. Male-biased sex ratios of fish
embryos have been reported near a pulp mill in broods of
eelpout (Zoarces viviparus) in the vicinity of a large kraft pulp
mill on the Swedish Baltic coast, suggesting that masculinizing
compounds in the effluent were affecting gonadal differentiation and promoting skewed sex ratios. Although androgenic
chemicals have been isolated from PME, efforts to date have
not conclusively identified the chemicals in PME responsible
for masculinization of the female fish (Durhan et al., 2002).
Effluents from cattle concentrated animal feeding operations
(CAFO) in Nebraska and Ohio have also been shown to display
androgenicity. Orlando et al. (2004) found that water
associated with a CAFO in Nebraska exhibited androgenic

activity and found that fish (fathead minnow; Pimephales
promelas) collected at the site displayed small gonads, fewer
embryos (Orlando et al., 2007) and morphological differences
compared with fish from a reference site. Durhan et al. (2006)
detected the synthetic androgens 17a-trenbolone and 17btrenbolone in water samples associated with a beef CAFO in
Ohio, where trenbolone acetate implants were used to stimulate
weight gain; samples collected from a direct discharge from the
feedlot displayed significant androgenic activity in vitro.
Complementary laboratory studies revealed both trenbolone
isomers were androgenic in the fathead minnow (Ankley et al.,
2003; Jensen et al., 2006) and the rat (Hotchkiss et al., 2007;
Wilson et al., 2002b). For example, in utero administration of
17b-trenbolone to dams resulted in masculinized female rat
offspring, displaying increased anogenital distance (AGD),
vaginal agenesis and induced male sex accessory tissues in
females (Hotchkiss et al., 2007; Wilson et al., 2002b).
Environmental estrogens. Much of the interest in environmental estrogens grew out of reports of reproductive cancers,
reproductive dysfunction, and potential behavioral alterations
of women who had been developmentally exposed to the
pharmaceutical estrogen, DES. Estrogens are critical for female
reproduction both developmentally and in adulthood. Two
different estrogen receptors (a, b) have been characterized in
mammals with 3 different receptors (a, b1, b2) identified in
teleost fish (Hawkins et al., 2005). Differential expression of
these receptors in tissues as well as different binding affinities
for various ligands suggests diversity in physiological function.
Studies with mammals have shown that estrogenic compounds are quite varied in structure and potency, including
pharmaceuticals (ethinylestradiol, DES), insecticides (methoxychlor, DDT, Chlordecone), surfactants (octyphenol, nonylphenol), phytoestrogens (genistein, coumesterol), sun
screens, and plastics (bisphenol A) (Gray et al., 2001a).
High dose oral in utero exposure to potent estrogens such as
ethinyl estradiol induces reproductive tract malformations in rats
with females affected at lower doses than male offspring. In
contrast, estrogenic pesticides or toxic substances have not been
shown to induce similar structural malformations. Perinatal oral
maternal exposure to weaker estrogenic chemicals like methoxychlor defeminizes the central nervous system (CNS) of the female
rat such that they are acyclic and infertile and have a shortened
reproductive life span due to an early onset of irregular estrous cycles. Male offspring from such studies are fertile but
occasionally display some effects on reproductive tissues at higher
dosage levels. Although one laboratory has reported that ip
injections of pregnant rats with high doses of methoxychlor during
gonadal differentiation induces testicular lesions and reduced
fertility in offspring, with such effects being transmitted through
several generations (Anway et al., 2005), other investigators have
not observed similar testicular effects or reduced fertility in F1
males using oral exposures (a more relevant exposure route for risk
assessment) during this period of development (Gray et al., 1989).
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Exposure of developing female rodents (rats and hamsters)
to ethinyl estradiol, methoxychlor, chlordecone, and zearalenone, for example, can result in altered reproductive behaviors,
sexually dimorphic nonreproductive behavior, neuroendocrine
function (estrous cycles, onset of puberty), fertility, and
reproductive tract morphology. Developing males are not
immune to the adverse effects of exogenous estrogens. Studies
with ethinyl estradiol in males showed altered testicular
development among other effects (Howdeshell et al., 2007).
Oral exposure to all potent and may xenoestrogens after
weaning of female rats causes pseudoprecocious puberty (early
vaginal opening), decreased food intake, and body weight,
altered activity, and altered reproductive behavior in both
males and females (Gray et al., 1989; Gray and Ostby, 1998).
Finally, there are ongoing discussions about the possibility of
low dose effects of this class of chemicals, especially
Bisphenol A, and this continues to be an active area of
research and debate about the reproducibility and relevance of
the low dose findings given the lack of adverse effects at any
dose level (CERHR, NTP Bisphenol A Expert Panel Final Nov
26, 2007) (Guillette, 2006).
Environmental AhR agonists. Exposure to Ah receptor
agonists such as TCDD, PCBs, and PCDFs has been causally
linked to developmental/reproductive toxicity in humans
(Brouwer et al., 1999; Guo et al., 1995), nonhuman primates
(Rier et al., 2001), rodents (see below), mink (Hornshaw et al.,
1983), fish (Ankley and Giesy, 1998), and other wildlife
species (Ankley and Giesy, 1998). Agonists of the AhR (which
is a cellular steroid hormone-like receptor) form a complex
with the receptor that acts as a transcription factor by binding to
specific DREs (dioxin response elements) on specific genes.
Some, if not all of the toxicity of TCDD, appears to result from
activation of the Ah receptor. TCDD is an ‘‘endocrine
disrupter’’ that acts on multiple components of the endocrine
axis. TCDD exposure alters the levels of many hormones and
growth factors, and their receptors (see Part II, Draft EPA
Dioxin Risk Assessment document: http://www.epa.gov/ncea/
pdfs/dioxin/part2/dritoc.pdf).
In addition to the effects of these chemicals seen in humans
from accidental exposures, exposure to very low doses of
TCDD produces infertility in rodent progeny (Bjerke and
Peterson, 1994; Bjerke et al., 1994a, b; Mably et al., 1992).
Exposure to a single low dose of TCDD ranging from 50 ng to
2 lg/kg during sex differentiation of the rat or Syrian hamster
results in a number of unusual reproductive alterations in male
and female progeny (Gray and Ostby, 1995; Gray et al., 1995,
1997b, c; Wolf et al., 1999). In female rats, gestational
exposure to TCDD induced clefting of the phallus with a mild
degree of hypospadias in females and a permanent ‘‘thread’’ of
tissue across the opening of the vagina of the progeny. Female
progeny, treated earlier in gestation displayed reduced
fecundity, a high incidence of constant estrus, and cystic
endometrial hyperplasia at middle-age. Female hamsters,
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exposed in utero with TCDD also displayed clitoral clefting,
reduced fertility as a result of several functional reproductive
problems, but they did not display the vaginal thread. In
TCDD-exposed male rat and hamster offspring, puberty was
delayed, ejaculated and epididymal sperm numbers were
reduced, whereas the reductions in ventral prostate, seminal
vesicle, and testis size, displayed during peripubertal life, were
attenuated with age. When administered chronically prior to
and throughout gestation, TCDD delays puberty in the male rat
at doses as low as 2.4 ng/kg/day (Bell et al., 2007).
Mating behavior was normal in male hamsters, whereas male
rats had some difficulty achieving intromissions. No malformations were noted in male rat or hamster offspring at these
dosage levels. Furthermore, a PCB congener, 169, is an Ah
receptor agonist with a toxic equivalency factor of about 0.001,
as compared with the potency of TCDD. PCB 169 treatment
during pregnancy alters reproductive development of Long
Evans hooded male and female rats in a manner almost
identical to TCDD (Gray and Ostby, 1998).
TCDD and related compounds also have been linked to
endometriosis in nonhuman primates (Rier et al., 2001) and
women (Louis et al., 2005). Exposure to TCDD is associated
with a dose-dependent increase in the incidence and severity of
endometriosis in the rhesus monkey and it was reported that the
serum levels of TCDD and specific dioxin-like PHAH
congeners were increased in TCDD-treated rhesus monkeys
with endometriosis 13 years after the TCDD exposure.
Other classes of vertebrates are adversely affected by low
concentrations of TCDD and related compounds. These
chemicals are toxic to some embryonic fish (Zabel et al.,
1995) and avian (Sanderson et al., 1994) species in the field
and in the laboratory.
NEW AREAS OF RESEARCH

Other Pathways Affected by EDCs
It has become apparent that endocrine disruption includes
mechanisms and targets beyond the traditional estrogen/
androgen/thyroid (EAT) receptor–mediated systems. Examples
of ‘‘nontraditional’’ endocrine disruption include various
inhibitors of the steroidogenic pathway including fetal Leydig
cell androgen production and aromatase inhibitors (Gray et al.,
2006). The herbicide, atrazine, binds to a new class of
membrane-bound progesterone receptors, inducing neuronal
mast cell degranulation in vitro (Mizota and Ueda, 2006) and
several EDCs have been reported to interact with membranebound estrogen receptors. However, the physiological role of
these receptors and the biological significance of these in vitro
observations have yet to be defined and for these reasons,
binding of these receptors can only be hypothetically linked to
adverse effects in vivo.
Recently, nitrates have come into focus as potential
endocrine disrupters. Although historically linked to
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methemoglobinemia, nitrates are capable of disrupting gonadal
steroidogenesis and thyroid function (Guillette, 2006). In
invertebrates, other receptor systems such as the retinoid
receptor systems (RXR) and ecdysteroids (EcR) play critical
roles in reproduction and growth (Rodriguez et al., 2006).
Recent evidence also suggests that EDCs may disrupt
terminal metabolism of endogenous and exogenous materials
by altering the activating hepatic enzymes. For example, the
pregnane X receptor receptor in the liver is upregulated by
numerous EDCs including nonylphenol, DDT, and methoxychlor in a way that alters the metabolism of various xenobiotics
and endogenous hormones (Kretschmer and Baldwin, 2005).
This altered metabolism may affect androgen and estrogen
levels as well as the balance of bound and free thyroid ligands
(Kretschmer and Baldwin, 2005).
In addition to novel mechanisms of action, nonreproductive
targets of EDCs have been identified. These targets include the
cardiovascular system, the digestive system, and adipose tissue
(WHO, 2002). Immune function, long known to be sensitive to
steroids, has also been identified as an EDC target (Inadera,
2006). Hormone receptors have been identified on various
immune cells and cytokine receptors localized to various
endocrine tissues and the brain. In addition, increasing
incidence of autoimmune diseases, sex differences in immune
function, and documented immunomodulatory effects of sex
steroids have highlighted the potential for endocrine-active
chemicals to affect this dynamic system. Examples of
chemicals interfering with immune function via endocrine
interactions have been described for numerous compounds
including androgens (Hotchkiss and Nelson, 2007), estrogens,
organotins, and dioxins (Inadera, 2006). Selgrade (2007) stated
that there is now sufficient data, at least for the effects of
toxicants on the developing immune system, to conclude that
the concern raised about human risk by the rodent data is
justified (Selgrade, 2007).
Another target of EDCs is the CNS. Not only are some
sexually dimorphic behaviors affected permanently by exposure to chemicals with androgenic or estrogenic activities (Gray
et al., 2006) neural development also can be altered by
exposure to thyroid-active EDCs (Schantz and Widholm,
2001). The hypothalamic-pituitary-adrenal axis also is a potential target of EDCs. Chemical activation of this system by
PCBs or through interactions with the glucocorticoid receptors
(Guillette, 2006; Johansson et al., 1998) can have adverse
effects on a number of different systems, thereby expanding the
number of potential targets for EDCs.
Mixtures
Mixtures of EDCs in the environment present a major
emerging issue for research and risk assessment. Toxicological
studies have typically focused on single chemical exposures
and their effects; however, exposure to mixtures in the
environment is the rule, not the exception (Kolpin et al.,

2002). It is essential to develop and validate methods to
accurately predict effects of endocrine-disrupting mixtures in
order to protect humans and wildlife from the risk associated
with potentially cumulative effects of these mixtures.
The evidence from both in vitro and in vivo studies
generally indicates that mixtures of EDCs with the same
mechanism of action display additive effects, however,
chemical mixtures also can act in an antagonistic or synergistic
manner. Initially, studies focused on estrogenic chemicals. For
example, in vitro studies using the yeast estrogen screen assay
(Payne et al., 2000), as well as the breast cancer cell
proliferation assay (Payne et al., 2001; Silva et al., 2002)
found that mixtures of xenoestrogens elicit additive activation
of the estrogen receptor. Furthermore, Silva et al. (2002)
showed that chemicals present at their no observed effect
concentrations contribute to a cumulative effect of the mixture.
In vivo studies by Brian et al. (2005) demonstrated that
a mixture of five estrogenic compounds induced vitellogenin in
male fish corresponding to predictions based on the concept of
concentration addition.
An increasing incidence of male reproductive tract developmental abnormalities highlights the importance of
assessing antiandrogenic mixtures for their potential effects
(Skakkebaek et al., 2001). Recent studies in our own lab have
demonstrated that in utero exposure to mixtures of chemicals
that target the androgen signaling pathway at multiple sites
(e.g., AR antagonists and inhibitors of testosterone) elicit doseadditive effects on the male rat reproductive tract (Gray et al.,
2001, 2006; Hotchkiss et al., 2004; Howdeshell et al., 2007;
Rider et al., 2008). The fact that chemicals that act on different
fetal tissues via diverse cellular mechanism of action produce
additive effects indicates that the current framework for
conducting cumulative risk assessments should not only
consider including chemicals from different classes with the
same ‘‘mechanism of toxicity’’, but also should include
chemicals that disrupt differentiation of the same fetal tissue
at different sites in the androgen signaling pathway.
In vivo studies (Birkhoj et al., 2004; Gray et al., 2001b,
2006; Hotchkiss et al., 2004; Nellemann et al., 2003) have
repeatedly found that mixtures of AR antagonists elicit additive
effects on young male rats exposed to the chemicals in utero.
Dose-additive effects also have been demonstrated in vitro
using AR activation assays (Birkhoj et al., 2004; Nellemann
et al., 2003). It is likely, for example, that androgen-dependent
tissues cannot discriminate in terms of cellular responses,
between the blockade of the AR and significantly lowering the
concentration of the ligand (T and/or dihydrotestosterone). It
would be reasonable to expect, therefore, that both of these
actions could produce dose-additive adverse responses in the
differentiating tissues.
The finding that mixtures of chemicals targeting endocrine
signaling at multiple levels adhere to dose additivity was also
observed with mixtures of thyroid disrupting chemicals
(Crofton et al., 2005). Overall, current mixtures research
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TABLE 2
Strategy for Ongoing Studies with Vertebrate and Invertebrate Estrogen and ARs
Invertebrate

Obtain animal tissues
Prepare complimentary
DNA library
Isolate ER or AR
Sequence ER or AR
Express ER or AR
ER or AR Function
Compare function
across species

Reptiles and amphibians

Fish
Rainbow
trout

Fathead
minnow

Japanese
Quail

Mammal

Mud
snail

Water
flea

Northern
Leopard Frog

Giant
Salamander

X
X

X
X

X
X

N/A
N/A

N/A
N/A

N/A
N/A

X
X

N/A
N/A

N/A
N/A

N/A
N/A

N/A
ERa1
ERa

N/A
ERa1
ERa
Ongoing

N/A
ERa3, AR2
ERa
AR
AR

ERa, AR
ERa, AR
Era, AR
Era, AR
ERa4, AR

N/A
ERa1
ERa

N/A
AR1
AR
AR
ARongoing

N/A
ERa1,AR1
ERa, AR
ERa, AR
ERa4, AR

Ongoing

American
Alligator

Bird

Chimpanzee

Human

Note. ERa1 ¼ sequence obtained from GenBank. AR2 ¼ expression vector generously provided by Takeo and Yamashita (1999); ERa3 ¼ expression vector
generously provided by F. Pakdel (Pakdel et al., 2000), ERa4 ¼ manuscript in preparation, N/A ¼ not applicable—sequence obtained from outside sources or
GenBank. Mud snail ¼ Ilyanassa obsolete, Water flea ¼ Daphnia magna, Northern Leopard Frog ¼ Rana pipiens, Japanese Quail ¼ Coturnix japonica, Giant
salamander ¼ Andrias davidianus, Rainbox trout ¼ Oncorhynchus mykiss, fathead minnow ¼ Pimephales promelas, American alligator ¼ Alligator
mississippiensis, Chimpanzee ¼ Pan troglodytes.

points to two major conclusions: (1) individual chemicals
present below their NOAELs contribute to overall mixture
effects and (2) true risk associated with exposure to EDCs can
only be determined when the cumulative effects of chemicals
that target a common signaling pathway are taken into
consideration.
Cross-Species Comparisons
Assessment of the validity of cross-species extrapolation is
problematic on several issues. Fish and wildlife are often
viewed as ‘‘sentinel species.’’ Hence, estrogenic and androgenic effects in animals in the environment are generally
assumed to be of concern to other species, including humans.
However, preliminary cross-species studies suggest that
surrogate laboratory species may not always be relevant to
the species of concern and that data from human health risk
assessments may not accurately reflect the risk to fish and
wildlife. Current prescreening protocols only include mammalian receptor-based assays, and thus may not provide as
accurate an assessment for fish and wildlife as would similar
assays utilizing receptors obtained from nonmammalian
species.
Assessing the impact of EDCs on fish and wildlife has been
facilitated by molecular cloning and gene synthesis (Table 2;
Wilson et al., 2004). Generation of cDNA libraries from
specific tissues can effectively immortalize and clone the genes
of a species, frequently utilizing only one animal or surgical
specimen. (Wilson et al., 2004b). These libraries act as
repositories for genes associated with endocrine function, as
well as providing a source of material for future studies.
Additionally, databases of gene sequences derived from

analysis of overlapping gene fragments provide information
for the synthesis and expression of an entire gene without
utilization of additional animals or tissues. Both approaches are
useful in generating an unlimited source of receptor proteins in
a controlled environment. These proteins can then be subjected
to binding assays using similar protocols, to determine if EDCs
affect steroid hormone receptors equally across species (Wilson
et al., 2007). These binding assays can utilize nonmammalian
recombinant receptors, in various stages of purification, or
expressed proteins in living cells. Both approaches provide
valuable data with regard to ligand binding, but provide little
information about how ligand–receptor–EDC interactions
might affect gene regulation. Current mammalian transcriptional activation assays, utilizing mammalian receptor and
receptor specific reporters in homologous cells lines, are more
fully developed than for lower vertebrates. However, generation of homologous cell lines and species-specific reporter
constructs would facilitate similar studies of alteration of gene
induction in fish and wildlife species.
The utility of any species in addressing EDC questions is
enhanced if species are from taxa not commonly studied, have
the potential for laboratory and field studies, have been affected
by EDCs in the wild and can help resolve conflicting reports of
receptor binding. Studies of the fungicide vinclozolin and its
metabolites have reinforced the validity of this approach to
species selection. Despite the high degree of homology in the
ligand binding domain of human and the fathead minnow AR,
subtle differences in the binding affinities for these EDCs have
been documented between mammals and fish, and suggest that
across species, the impact of a given EDC may vary (Wilson
et al., 2004b, 2007). Similar studies comparing the estrogen
receptor (ER) binding affinity of plasticizers across animal
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classes have also documented differences, and established
the need for additional studies assessing the effect of EDCs
on other receptors (e.g., the estrogen receptor) of diverse
species (Rider et al., in press). This is needed to fully assess the
default assumption that the interaction of EDCs with steroid
hormone receptors in one species can be extrapolated to
another.

REGULATORY SCREENING AND TESTING

Mammalian Screening and Testing
One response of the USEPA to the Safe Drinking Water and
Food Quality and Protection Acts of 1996 was to form an
advisory group, the Endocrine Disruptor Screening and Testing
Advisory Committee (EDSTAC), to help formulate a tiered
screening and testing strategy for EDCs (http://www.epa.gov/
scipoly/oscpendo/edspoverview/finalrpt.htm). The screening
battery recommended by EDSTAC was designed to detect
alterations in developmental and reproductive processes
controlled by the hypothalamic-pituitary-gonadal (HPG) and
hypothalamic-pituitary-thyroid (HPT) axes. Based on
a ‘‘weight-of-evidence’’ analysis, chemicals positive in Tier 1
screening (T1S) would be considered as potential EDCs and
subjected to testing (Tier 2). Because T1S would be less
expensive and time consuming than Tier 2 testing, equivocal
effects in T1S could be replicated or evaluated further in
additional short-term assays before more extensive Tier 2
testing was initiated. The goal of T1S is to use assays sensitive
enough to detect EDCs, whereas issues of ‘‘dose–response,
relevance of the route of exposure, sensitive life stages and
adversity’’ would be resolved in the Tier 2 testing phase.
In vitro T1S assays that are under development would
evaluate chemicals for AR and ER binding with rat AR and ER
cytosolic, rat AR recombinant, and human ERa recombinant
receptors, ER or AR dependent gene expression (Wilson et al.,
2002a, 2004a) or cell proliferation (Soto et al., 2004) assays,
aromatase enzyme inhibition, and inhibition of steroidogenesis
in the H295R cell line (Heneweer et al., 2004). Due to
limitations of in vitro assays, it is necessary to include in vivo
assays in the screening battery. In vitro assays alone cannot
account for absorption, distribution, metabolism, and excretion
(ADME), and they yield false negative and false-positive
results. In particular, many false negatives result from the
inability of the in vitro assays to activate EDCs metabolically.
In addition, in vitro assays at high concentrations lack
specificity and produce many false-positive results. Because
in vivo assays not only account for ADME, but also can
integrate all of the endocrine and nonendocrine toxicities, the
combination of both in vivo and in vitro assays is recommended for screening.
To avoid the limitations described above, the EDSTAC
proposed three short-term in vivo mammalian assays for the

T1S battery: the uterotropic, Hershberger, and pubertal female
rat assays (Gray, 1998a). Estrogen agonists and antagonists
would be detected using the 3-day uterotropic assay using
subcutaneous administration of the test compound. Based on
the evaluation of four variations of the uterotropic assay
protocol in organization for economic cooperation and development (OECD) interlaboratory studies, all of the protocols
have produced acceptable responses without regard to rat
strain, diet, or housing conditions (Owens and Koeter, 2003;
Owens et al., 2006). The selected uterotropic assays for
estrogens and antiestrogens use either the intact juvenile or the
castrated ovariectomized adult/juvenile female rat that is dosed
either by oral or subcutaneous routes.
The second in vivo assay in T1S, the Hershberger assay,
detects antiandrogenic activity simply by weighing androgendependent tissues in the castrated male rat (Gray, 1998a, b;
Hershberger et al., 1953; Owens et al., 2006, 2007). In this
assay, weights of the ventral prostate, Cowper’s glands,
seminal vesicles (with coagulating glands and fluids), glans
penis, and levator ani/bulbocavernosus muscles are measured
in castrated, testosterone-treated (or untreated) male rats after
10 days of oral treatment with the test compound. This assay is
very sensitive for detection of androgens and antiandrogens.
Other useful end points that help reveal the mode of action and
specificity of the response include weights of the adrenal, liver,
and kidney, and measurements of serum (collected by cardiac
puncture) levels of testosterone and luteinizing hormone. The
Hershberger assay shows high sensitivity and specificity to
chemicals with AR-mediated activity. Weak antiandrogenic
pesticides such as p,p#-DDE and linuron are easily detected in
the Hershberger assay (Lambright et al., 2000; Parks et al.,
2000; Yamasaki et al., 2003). Chemicals such as finasteride,
which inhibit 5a reductase activity, also are active in this assay.
5a Reductase inhibitors dramatically reduce male accessory
sex gland weights with less effect on the levator ani/
bulbocavernosus muscle, which has low levels of this enzyme
(Blohm et al., 1986). Chemicals that are positive in the
Hershberger assay often produce adverse effects after in utero
exposure and during puberty.
Both the rat uterotropic and Hershberger assays have been
used for several decades to screen chemicals for estrogenicity
and androgenicity (Dorfman and Dorfman, 1962). Because
estrogens are required for uterine growth and androgens for sex
accessory gland growth in both rats and humans, chemicals that
are positive in the rat assays for these endocrine activities can
be expected to produce predictable responses in humans. These
endocrine pathways are highly conserved; in fact, many drugs
with antiestrogenic activity or antiandrogenic activity have
been shown to produce the anticipated responses in both
species. The OECD-led effort to standardize and validate the
Uterotrophic and Hershberger assay has been completed with
several publications on the different phases available, and
OECD test guidelines for both these assays have been peerreviewed, public comments addressed and are listed as draft
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Test Guidelines on the OECD web site: http://www.oecd.
org/document/62/0,3343,en_2649_34377_2348606_1_1_1_1,
00.html#Hershberger.
The third in vivo mammalian/rat assay included in the
proposed EDSTAC T1S battery, the pubertal female rat assay,
has been used in our laboratory for nearly two decades (Gray,
1998a; Gray et al., 1988a, b, 1989). This assay detects
alterations in thyroid hormone status, HPG function, inhibition
of steroidogenesis, and direct effects of estrogens, and
antiestrogens. In this assay, weanling female rats are dosed
daily by gavage for 21 days while the age at vaginal opening
(puberty) is monitored. The females are necropsied at about
42 days of age and measurements include serum thyroid
hormones, uterine and ovarian weight, and histology (reviewed
by Goldman et al., 2000) (http://www.epa.gov/oscpmont/
oscpendo/pubs/assayvalidation/pubertal_female_pr.htm).
Alternative in vivo assays were also discussed by EDSTAC
and are being evaluated by the EPA. If they are of sufficient
sensitivity, specificity, and relevance, they might replace or
augment current T1S assays.
One promising alternative assay also used extensively in our
laboratory is the pubertal male rat assay (Gray et al., 1999;
Kelce et al., 1995; Monosson et al., 1999; Stoker et al., 2000),
which detects alterations in thyroid function, HPG maturation,
steroidogenesis, and altered steroid hormone function. Intact
weanling males are exposed to the test substance for
approximately 30 days during which the age at puberty is
determined by measuring the age at preputial separation, and
reproductive tissues are evaluated and serum taken for optional
hormonal analyses at necropsy. We suggest measurement of
serum testosterone be included because it would assist in
determining chemical mode of action (e.g., separating AR
antagonist vs. inhibitors of hormone synthesis) and enhance the
sensitivity of the assay to chemicals that inhibit steroid
hormone synthesis: http://www.epa.gov/oscpmont/oscpendo/
pubs/assayvalidation/pubertal_male_pr.htm.
The EDSTAC recommended that the EPA develop and
evaluate an in utero lactational screening assay due to the
unique sensitivity of the fetal reproductive system to disruption
by some toxicants. For example, TCDD alters sexual
differentiation of male and female rats and hamsters at dosage
levels approximately two orders of magnitude below those
required to produce adverse effects in pubertal or adult rats
(Gray et al., 1997b, c; Wolf et al., 1999). One version of the
proposed in utero lactational assay now being evaluated by the
EPA takes about 80 days and uses approximately 10 litters per
group (120–150 pups). In this protocol, androgens and
antiandrogens can be detected in approximately 2 to 3 wk,
and EDCs with antithyroid activity can be detected in infant or
weanling offspring after 4–5 weeks of maternal treatment.
However, an EPA Science Advisory Panel recently concluded
the above protocol is more suitable for testing than use as
a screening assay due to the size and duration of the study but
that efforts to streamline such an assay for use in screening
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were worthy of consideration, http://www.epa.gov/scipoly/sap/
meetings/index.htm#january. A scaled-down protocol that
might be useful for screening with in utero and lactational
exposure could include five to six dose groups over a broad
dose range, three to four litters per dose group and carefully
examine all the pups of both sexes (i.e., Rider et al., 2008). If
effects were noted, then this would be followed by a definitive
multigenerational study to define NOAELs.
Tier 2 Testing as Defined by EDSTAC and the USEPA
The purpose of Tier 2 testing is to provide ‘‘definitive’’
information for hazard characterization of endocrine-disrupting
agents. This information adds to the body of knowledge
essential for risk assessment for an EDC by
1. Either confirming or refuting the observations noted in
the T1S screens/assays. The Tier 2 in vivo assays data can
expand on the information derived from the in vitro and in vivo
screens and use a route of exposure that will be reflective of
likely exposure of humans to the agent under investigation.
2. For the first time in the tiered process, studies involving
mammals utilize an in utero exposure paradigm that includes
exposures in critical developmental windows and assessments
not evaluated in standard prenatal developmental toxicity
studies. For many EDCs, this is the most sensitive life stage for
the induction of adverse effects leading to potentially
permanent changes in phenotype and function that would not
be noted in adult animal toxicity studies.
3. Identifying in the experimental animal species (most likely
the rat) the activity of suspected EDCs for end points for which
concerns have been raised in humans (e.g., hypospadias,
cryptorchidism) as well as identify other endocrine-like activity associated with androgens, estrogens, and antithyroid acting agents.
4. Not only detecting activity, but also providing the
appropriate dose–response information for use in any risk
assessment on individual chemicals.
When the EPA first proposed a Tier 2 test for mammals it
noted that the multigeneration study (Fig. 1) was the only one
likely to have an appropriate exposure period covering the
major developmental life stages of interest. EPA also had built
into the protocol, appropriate times for evaluations of effects,
especially those that might show latency (e.g., an exposure
in utero only producing a readily identifiable change at
adulthood). Even though the improvements in protocol study
design in the most recent EPA test guidelines (http://
www.epa.gov/opptsfrs/publications/OPPTS_Harmonized/
870_Health_Effects_Test_Guidelines/Series/870-3800.pdf) did
incorporate more endocrine-mediated end points (e.g., sperm
analyses, indices of puberty in males and females), EDSTAC
realized that some improvements would have to be made to the
end points incorporated in the multigeneration protocol to
make the assay more comprehensive in the detection of effects
(e.g., improved pathology and endocrine assessment, sexually
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FIG. 1. Schematic of a standard multigenerational test.

dimorphic phenotypic assessments). It was also noted that
many registrants and producers could bypass T1S screening
and go directly to Tier 2 (e.g., for pesticides), but that the
current protocols might be insensitive to both detection and
providing accurate dose–response information.
There is also a large gap (in terms of comprehensiveness and
cost) between the T1S screens and Tier 2 tests. Many
investigators had successfully used a transgenerational approach (usually employing approximately 10 litters per dose
group but analyzing every pup in the litter on reaching
adulthood) which employed fewer animals, and was significantly cheaper than a standard multigeneration study in
identifying adverse endocrine-mediated end points or found
them at lower dose levels than seen in conventional multigeneration studies (e.g., linuron, Gray et al., 1999; Lambright

et al., 2000; McIntyre et al., 2000; di-iso-nonyl phthalate, Gray
et al., 1999; Waterman et al., 2000).
The use of a lower litter number but increasing the number
of pups per litter examined provides greater statistical power
over the conventional multigeneration study with 20 litters per
dose group, but evaluation of only one male and one female
offspring per litter at adulthood. The degree to which the
statistical power increases with examination of multiple pups
per litter is dependent upon the degree to which pups within
a litter differ from one another (the intralitter correlation
coefficient [ICC]). We have calculated ICCs and determined
how examining multiple male pups in a litter affected the
power calculations for a number of reproductive end points
from several of our studies. In these studies, dams were
exposed to EDCs in utero and the offspring examined later in
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TABLE 3
Calculation of Cox’s Ratios and ICC From proc Mixed Analyses
Adult necropsy
weight data

Litter variance

Pups-residual variance

Cox’s ratio 4 3 (pups/litters)

ICC litter/(litter þ pups)

Epididymis
Liver
Body
Kidney
Cowper’s glands
Testis
LABC
Glans penis
Seminal vesicle
Ventral prostate

5021
4.95
2579
23,537
1129
21,506
10,417
31.2
25,980
5346

5167
6.22
3481
32,670
1694
32,376
15,736
56.5
71,543
23,258

4.116
5.031
5.399
5.552
6.002
6.022
6.042
7.244
11.015
17.402

0.493
0.443
0.426
0.419
0.400
0.399
0.398
0.356
0.266
0.187

Variable pubertal
necropsya
Body weight,
day 18
Body weight,
day 44
Body weight final
AGD, day 2
Glans penis weight
Epididymis weight
Testis weight
LABC
Seminal vesicle weight
Adrenal weight
Age at preputial separation
Weight at preputial separation
Cowper’s glands

Litter variance

Pups-residual variance

Cox’s ratio 4 3 (pups/litters)

ICC litter/(litter þ pups)

14.225

7.131

2.005

0.666

348.2

201.02

2.309

0.634

753.87
0.05503
44.4
839.64
23,297
2666
4925
8.214
1.391
107.00
14.9954

492.14
0.06889
70.85
1708.64
61,044
7417.5
14,445
34
8.0744
720.00
189.57

2.611
5.007
6.383
8.140
10.481
11.129
11.732
16.719
23.219
26.916
50.568

0.605
0.444
0.385
0.329
0.276
0.264
0.254
0.193
0.147
0.129
0.073

Note. LABC, levator ani bulbocavernosus weight. Power curves flatten out when the number of pups sampled per litter exceeds Cox’s ratio (Bergerud, 1995).
End points are ordered based upon ICC values, ranging from high (pups more correlated within the litter) to low (pups less correlated within the litter).
a
The ‘‘pubertal’’ necropsy included all the males dosed by gavage from 18 to 65 days of age with the same dose level administered to the dam during gestation
and lactation. For males necropsied as adults, only the dam was treated and exposure was discontinued on day 18 of lactation. The lower the ICC, the less related
are the values of the pups within litters.

life. In the data shown here as an example, DEHP was
administered to the dam orally from day 8 of gestational to day
18 of lactation, half the male rat offspring being further
exposed from 18 to 65 days of age and all the males were
examined thoroughly (Gray et al., unpublished data). The
results of the DEHP study indicate (Table 3; Fig. 2) that
sampling two to three pups from 15 litters, or all of the pups
from ten litters/dose provides the same or greater statistical
power as sampling one pup from 20 litters. More information
on these calculations is provided in the text below.
Using more pups per litter also addresses the issue of
statistical power to detect malformations that occur at low
incidences in the lower dosage groups. It is not just the
continuous variables but also the malformations that can have
improved detection and provide better assessments of dose–
response relationships (Fig. 2).
These studies also did not employ triggered end points, but
made measurements in all offspring and used other sensitive

measures of endocrine activity (e.g., anogenital distance in F1
offspring, assessment of areola and nipple retention in
preweaning F1 pups and at adulthood) not currently incorporated into standard multigeneration studies. Such transgenerational studies may offer an intermediate tier between
T1S and Tier 2. Although they do not evaluate the reproductive
performance of the F1 offspring, such studies could serve as
a less expensive intermediate tier to re-enforce the occurrence
of endocrine activity that was flagged in T1S, before
embarking on any modified multigeneration study, or perhaps
could act as a bridging study from an older multigeneration
study.
Whatever improvement may be required in the current EPA
multigeneration protocols that would serve as the definitive
Tier 2 test it would be prudent to think that all the information
obtained in T1S should be used in tailoring the study design to
move away from a ‘‘one size fits all’’ approach. If no T1S data
are obtained, Tier 2 must represent a comprehensive evaluation
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FIG. 2. Power curves for reproductive organ weights, malformation rates, anogenital distance and age at preputial separation (puberty). The data from our
transgenerational study with DEHP were analyzed using PROC MIXED available on SAS to obtain estimates of components of variation (for litters vs. pups within
litters) that make up the overall variability of the means in order to assess the implications for statistical power of using data from multiple pups per litter. Following
this analysis, we calculated power to detect the treatment effects as described by Raudenbush and Xiao-Feng (2001). The objective of this was to determine the
proportion of the overall error variance due to litter-to-litter variability versus the proportion accounted for by the pups within litters. This retrospective analysis can
be useful for designing optimal sampling strategies for future studies. It basically allows one to determine how much the statistical power of a study is enhanced by
examining several pups from the same litter rather than using only one pup/per sex/litter. Because the pups in the DEHP treated litters do not respond identically,
the more variable the pups are within the litter the more power is enhanced, and hence the standard error of the mean is reduced, by examining multiple pups from
the same litter.
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of activity with sufficient statistical and experimental power to
be able to detect events likely to have an endocrine-mediated
mode of action (e.g., reproductive tract malformations). The
current studies with limited end points and numbers of
offspring examined per litter, have much poorer resolving
power than, for example, the current prenatal developmental
toxicity study to detect birth defects, such that incidences of
reproductive tract malformations in excess of 25% with a very
low control background incidence cannot be detected.
Newer efforts to move to a more tailored approach to
studying reproductive toxicity have been proposed by the
Agricultural and Chemical Safety Assessment committee of
ILSI (Cooper et al., 2006). This life-stage approach, although
never having been tested, contains many end points and
approaches that have been used successfully in the past and
acknowledges that a flexible approach needs to be taken based
on all the available information to adequately test for
reproductive toxicity, including those aspects of postnatal
development that have been of serious concern in the
evaluation of EDCs. However, only three chemicals are being
selected with known reproductive, neuro- or immunotoxicity
for evaluation in the protocol. This approach is based on many
of the transgenerational types of studies that have been
previously published. The authors also acknowledge the
weakness in having too few pups to examine in every litter
and advocate testing more, in different cohorts that would
evaluate neuro- and immunotoxicity.
Whilst this represents a new initiative to incorporate the best
science into testing, the protocol presented in the publication
unfortunately fell short of the ideal, definitive test for EDCs. In
particular, the different cohorts of animals are examined at
different times so that at sexual maturity (usually deemed to be
~90 days of age in the rat) there is only 1 cohort available with
1 male and 1 female representative of the original litter, which
is no better than we have with the current multigeneration
protocol. In common with the transgenerational studies, there is
no routine evaluation of the reproductive performance of the F1
offspring. These shortcomings have been discussed and an
improved protocol was presented to a USEPA Science
Advisory Panel in, 2007 and this effort is being pursued by
the OECD.
Cooper et al. (2006) advocated the use of triggers to
incorporate additional end points into the design. Unfortunately, our experience with triggered end points in the current
EPA multigeneration study design has not been good. In many
instances, this is not a fault of the experimenters, but more
because of lack of time for evaluation of data. So, for example,
male pubertal indices are captured on the study around
postnatal day 45. With the normal staggering of individuals
on a reproduction study (not all are born on the same day) it
would be several days, or even longer if an effect is noted,
before all the males had complete evaluations of puberty. These
data would then need to be statistically analyzed corrected for
body weight and any other confounders and then a decision
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made on the conduct of a triggered endpoint (which may
involve a Contract Research Organization contacting sponsors
for approval). This may have to be done within 40 days, which
places significant pressure on the scientists conducting these
studies and may not be reliably achievable. A much better
approach would be the application of ‘‘opt out’’ triggers. That
is, all the end points for a study would be collected unless there
was sufficient information and justification not to undertake
a specific measurement. As the protocol currently exists in its
published form (Cooper et al., 2006), this would not suffice as
a replacement for the current multigeneration study, but could
be adapted to make it meet this need and we are optimistic that
this approach will serve as a useful template which can in time
be fashioned into a very useful protocol.
Power Calculations, Analysis of Components of Variation,
and Intralitter correlation coefficients
The data for our DEHP transgenerational study were
analyzed using PROC MIXED available on SAS to obtain
estimates of components of variation (for litters vs. pups within
litters) that make up the overall variability of the means in
order to calculate power to detect the treatment effects
(Raudenbush and Xiao-Feng, 2001) (Fig. 2; Table 3). Because
the pups in the DEHP treated litters do not respond identically,
the more variable the pups are within the litter the more power is
enhanced by examining multiple pups from the same litter. We
also employed Cox’s Ratio as a general rule to determine how
many pups per litter could be sampled to enhance the power of
the study (Bergerud, 1995) (http://www.for.gov.bc.ca/hre/biopamph/pamp50.pdf). ICC also were calculated to describe the
degree of similarity of pups within litters for the multiple end
points measured in the current study. According to Cox’s Rule Of
Thumb (Bergerud, 1995) there is little or no increase in power
when the number of subsamples (pups in this case) is greater than
Cox’s Ratio [Cox’s ratio ¼ 4 3 (variation due to pups within
litters/variation due to litters)]. The power curves flatten out
when the number of pups/litter sampled is increased, indicating
that the most efficient design would not sample any more pups
per litter beyond this Ratio. When the components of variance
were estimated for reproductive measures it is clear that, even in
the most conservative case, sampling all the male pups in each
litter would enhance the power of a transgenerational reproduction study. As examples, power curves were calculated
for the control and high dose group (300 mg/kg/day) for one to
five pups per litter and 10, 15, and 20 (standard sample size)
litters per dose.
Power calculations also were calculated for categorical
effects based upon the numbers of malformed males versus
males without malformations per dose group using SigmaStat
3.1 software (Fig. 2). If 20 animals per dose group are
examined for malformations then lesions occurring at an
incidence of 25% or greater can be detected whereas an
incidence of 10% can be detected if all the pups are examined
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from 20 litters. If only ten males per group are examined, as
recommended for histopathological analyses in some regulatory agency test guidelines, then effects are only detected
statistically if about 50% or more of the tissues/organs are
affected; a level of statistical power that many would consider
inadequate.
Nonmammalian Screening and Testing
As discussed previously, there is compelling evidence for
adverse effects of EDCs on invertebrates, fish, and wildlife.
This has provided one impetus for the development of EDC
screening and testing assays with nonmammalian species;
however, there also are examples where nonmammalian
models may prove superior to rodents in detecting some
EDC MOA.
The class of animals that has received the most attention in
terms of EDC testing is fish. Many different methodological
approaches have been applied in fish EDC tests; an
experimental design that has been used quite frequently is
a 21-day assay initiated with reproductively mature adults.
Different freshwater small fish models, including the Japanese
medaka (Oryzias latipes) and zebrafish (Danio rerio), have
been used in 21-day EDC screening assays (Seki et al., 2006);
however in the United States, the small fish species of choice
for the 21-day design has been the fathead minnow
(Pimephales promelas; status of this and other assays reviewed
at (http://www.epa.gov/endo/pubs/assayvalidation/status.htm).
The 21-day Tier 1 fathead minnow test features a range of
apical and mechanistic end points designed not only to detect
the adverse reproductive effects of exposure to the test
chemicals, but target specific classes of EDCs (Ankley et al.,
2001). For example, an endpoint in the assay that is exquisitely
sensitive to (and specific for) estrogenic EDCs is induction of
vitellogenin (egg yolk protein) in males, which, under normal
physiological conditions, do not express the protein (Ankley
et al., 2001; Seki et al., 2006). Decreases in plasma
vitellogenin concentrations in females have been shown to be
indicative of inhibitors of steroidogenic enzymes, including
CYP19 aromatase (Ankley et al., 2005). The 21-day assay also
is effective in identifying androgenic EDCs, in that female fish
exposed to AR agonists exhibit readily apparent morphological
masculinization (Ankley et al., 2001; Seki et al., 2006).
Fish also are being used in longer-term (e.g., Tier 2) tests to
detect full life-cycle and multigenerational effects of EDCs.
Species that have received the most attention in the United
States in this regard have been an estuarine fish, the sheepshead
minnow (Cyprinodon variegates), and the Japanese medaka,
which is attractive for this work due to its relatively rapid life
cycle (Ankley and Johnson, 2004). The medaka also is widely
used in Japan for long-term EDC testing, as is the zebrafish in
some European countries (Peterson et al., 2001). Responses
assessed in the longer-term EDC assays with fish are similar to
the apical and diagnostic end points used in the 21-day

reproduction tests, but typically also include measurements
reflective of chemical effects on the endocrine system during
early life stages, such as gonadal development and sexual
differentiation in F1 and, perhaps, F2 generations (Ankley and
Johnson, 2004).
Amphibian species have received significant attention in the
development and implementation of EDC testing programs as
recommended by EDSTAC. Amphibian metamorphosis is
almost certainly the most visually obvious manifestation of
effects on HPT function in a vertebrate; from this, it was
initially recommended that a simple tail resorption assay with
the model lab species Xenopus laevis could serve as the basis
of a screen for chemicals that act as agonists or antagonists of
thyroid hormone function. Subsequent research suggested that
the tail resorption endpoint was for various reasons problematic, but metamorphic frogs nonetheless were a good model for
detecting thyroid-active EDCs (Degitz et al., 2005; Opitz et al.,
2006). Currently the endpoint that seems best suited for this
purpose is thyroid gland histology, collected in conjunction
with some indication of developmental stage; this basic
approach (with X. laevis) is being used for EDC screening
programs being implemented both by the USEPA and
Organization for Economic Cooperation and Development
(Degitz et al., 2005; Opitz et al., 2006).
There has been interest in North America in the development
of a full life-cycle test with amphibian species that could serve
as a tool (e.g., in Tier 2) for assessing the long-term ecological
risk of EDCs. Research in this area has focused more on
Xenopus tropicalis than X. laevis, due in large part to the more
rapid life cycle of the former species (Degitz, unpublished
data). In addition to considering responses controlled by
thyroid function, such a test would feature end points (e.g.,
vitellogenin production, gonad histopathology) related to
disruption of the HPG axis by (anti-)estrogenic/androgenic
chemicals (Degitz, unpublished data).
In addition to fish and amphibians, there have been efforts
with other nonmammalian vertebrates to develop standardized
assays suitable for assessing the effects of EDCs. A notable
effort in this regard involves birds. Full life-cycle tests with
birds have been used for some time for pesticide registration;
with some adaptation, these basic tests would be applicable to
Tier 2 testing of EDCs (Touart, 2004). For example, to detect
possible transgenerational effects, it has been proposed that the
test design encompass two generations of animals, with (dietary)
chemical exposures starting with sexually mature adults,
proceeding through a complete F1 generation, and culminating
with production of F2 young. Either of two species would be
amenable to this type of experimental design; however, due to
their relatively more rapid life cycle, the Japanese quail
(Coturnix japonica) likely would be a more resource-effective
model than the northern bobwhite quail (Colinus virginianus)
for routine testing. In addition to apical responses like fecundity
and fertility, end points specifically indicative of endocrinedisruptive effects, like gonad development and differentiation
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and certain changes in behavior, are being incorporated into the
two-generation avian test design (Touart, 2004).
There also have been efforts to develop standardized tests for
EDCs with different invertebrate species (deFur, 2004). A
challenge in this area has been definition of what invertebrate
tests are intended to detect because the role, if any, of many of
the mammalian steroidal and protein hormones is uncertain in
invertebrates. If the assays are to be used to identify chemicals
that affect the vertebrate HPG axis, then there is some question
as to whether functional aspects of the axis are sufficiently
conserved across animal phyla to expect that sensitive,
biologically meaningful tests could be developed in invertebrate models. On the other hand, invertebrates possess a variety
of endocrine systems/function that could be adversely affected
by chemicals, which often would not be ‘‘flagged’’ as EDCs
using vertebrate tests (deFur, 2004). Under this scenario there
is an easily justifiable need for standardized tests for EDCs
using invertebrate models. One test recommended for inclusion
in the formal EPA testing program for EDCs is a life-cycle test
with Mysid shrimp. Other invertebrates that have received
significant attention relative to full life-cycle tests for EDCs
include daphnids and copepods (deFur, 2004).
CONCLUSIONS

The field of endocrine disrupters has come a long way since
its initial impetus in 1991. Many of the concepts advanced in
this area have now been embraced by the general toxicological
community resulting in useful enhancements of testing assays,
new mechanism-based screening assays and incorporation of
toxicant-induced endocrine alterations into risk assessment.
Concepts such as the special susceptibility of the developing
organism and early induction of latent effects, for example, are
now widely held and the mechanism-based approach to
toxicology testing and screening has been incorporated into
many other branches of toxicology. Parallel to the EDCs there
also is and emerging field of ‘‘developmental basis of adult
health,’’ or ‘‘fetal programming of adult disease’’ (de Boo and
Harding, 2006; Young, 2001). This hypothesis is a variation of
the many of the EDC concepts, but applies to potential adverse
effects on endpoints such as blood pressure, pancreatic
function, insulin sensitivity, and even brain and lung function.
The concept is the same: exposure during development may
induce profound changes in adult function, and extends that
concept past the endocrine system.
Since the Wingspread Conference of 1991, there have been
numerous examples of adverse effects of EDCs in fish,
wildlife, domestic animals, and humans. Endocrine systems
have been disrupted by anthropogenic chemicals including
antiandrogens, androgens, estrogens, AhR agonists, inhibitors
of steroid hormone synthesis, antithyroidal compounds, and
retinoid agonists. In addition, potential pathways and targets
for endocrine disruption extend beyond the traditional EAT
receptor–mediated reproductive and developmental systems.
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TABLE 4
Where Do We Go from Here?
1. Ecosystem health
1.a. Better characterization of the extent and population impacts on fish of
estrogenic municipal effluents, and further research concerning the
possible impacts on fish and wildlife of other known EDCs entering the
environment (e.g., from pulp and paper mills, CAFOs).
1.b. Clearer delineation of exact chemicals responsible for effluent
estrogenicity (i.e., ethinyl estradiol vs. E2 vs. nonylphenol) as a basis for
identifying mitigation options.
1.c. Identification of pharmaceuticals that could possibly cause ecological
effects through properties similar to EDCs, that is, high-potency
chemicals focused on biological pathways (other than the HPG axis) that
have a substantial degree of phylogenetic conservation.
2. EDC screening
2.a. Evaluation of the EPA T1S assay suite to determine ‘‘holes’’ and
redundancies with respect to identifying HPG-active chemicals (i.e., we
aren’t going to be able to apply the full suite of tests to very many
chemicals-too expensive); an understanding of endpoint/species
extrapolation will be critical here.
2.b. Improve predictiveness of screens and tests for EDC activities.
2.c. Enhance and expand the in vitro assays for T1S to replace animal-derived
proteins with recombinant receptors, adapt in vitro assays for high
throughput.
2.d. Determine the need for in vitro assays using nonmammalian pathways
and develop the assays for screening, as warranted.
2.e. Develop an in utero lactational screening assay for possible inclusion in T1S.
2.f. Implement a T1S battery that meets or exceeds the EDSTAC 1998
recommendations.
3. Multigenerational and transgenerational testing including a postnatal
examination of offspring
3.a. Enhanced multigenerational assays that include sensitive and reliable end
points, that use animals more efficiently (fewer litters/dose, examine more
pups/litter, increase histopathological examinations to include all F1
animals) without losing statistical power.
4. Clearer communication and cross-disciplinary training on the following:
4.a Appropriate experimental designs and statistical analyses of postnatal
study data for scientists from different disciplines as well as understanding of
basic toxicological issues (endocrinology, toxicogenomics, proteomics,
epigenetics, etc.) so that research resources are not wasted. It is evident from
the literature that special attention needs to be given to assure that studies
that examine more than one pup per litter account for this in the analysis of
the data. Furthermore, investigators that cross-foster pups should do so
properly, retaining both prenatal and postnatal litter information.
4.b Use of reproductive and developmental toxicity data in risk assessment.
Promote an understanding of the difference between and no observed effect
level and a NOAEL and the need to causally link effects not generally
recognized as adverse to clear adverse effects.
5. Maintain an integrated biological approach to study endocrine action (beware
of systems biology and the drilling down to molecular levels in vitro as cells
and tissues live in complex environments). Integrate EDC latent effects
research with other projects on the fetal basis of adult disease.
6. Risk assessment on EDCs
6.a. Develop a scientifically defensible and rational framework for cumulative
risk assessments, incorporating the knowledge that dose additivity
applies to chemicals that target the same endocrine pathway via very
different cellular mechanisms. This redefines what we mean by mode of
action and encompasses multiple mechanisms inducing the same
phenotypic changes.
6.b. Expanded use of endocrine data in risk assessments not only to support
mode of action but also as critical effects.
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Although much has been learned over the past 15 plus years,
future research needs to address critical issues that have arisen
since the early 1990#s. For example, reports of nonmonotonic
(e.g., U-shaped), and low dose effects and nonthreshold effects
for EDCs continue to be a challenge for risk assessment. Future
well-designed studies are required to address the biological
plausibility of low dose effects as well as the ramifications for
risk assessment. Furthermore, new mechanisms of endocrine
action continue to be discovered. Membrane-bound steroid
receptors, novel inhibitors of steroidogenesis, and altered
metabolism are just a few of the new areas of investigation.
In addition to the remaining questions of the field, there are
multiple emerging areas to be investigated. One of these areas
involves mixtures toxicology. It is clear that, rather than
focusing on single chemical exposures, data are required to
determine and predict potential cumulative effects of EDCs.
Pharmaceuticals and veterinary drugs in the environment also
present a new challenge. Pharmaceuticals, be they from
personal, medical, or agricultural uses have been detected in
the environment and these chemicals may be disrupting both
target and nontarget systems in exposed populations of wildlife
and fish (Ankley et al., 2007). The potential role of EDCs in
nontraditional biological pathways also warrants further investigation. Studies implicating EDCs in diabetes, obesity, and
behavioral and immune deficiencies have underscored the need
to elucidate these areas of endocrine disruptor research. These
new areas of research may eventually alter the screening and
testing batteries currently proposed by regulatory agencies
such as the USEPA and OECD. Until that time, there are
fundamental questions remaining about the proposed batteries
of screens and tests as described above. Finally, from a
regulatory standpoint, current interest in using toxicogenomic
data for risk assessment requires further evaluation. Inherent
problems with variability, reproducibility, and biological significance continue to challenge application of these promising
technologies. Risk assessors have traditionally required that
changes in gene expression be validated by some other
measure such as endocrine or biochemical ‘‘biomarkers’’ such
that a causal link can be established between mechanistic
data and an effect that is clearly adverse. Furthermore, one then
needs to identify a ‘‘point of departure’’ or the degree of
change in the mechanistic endpoint that consistently produces
an adverse effect.
In summary, research on EDCs has progressed significantly
and now provides concrete examples of chemicals in the
environment adversely affecting endocrine systems in diverse
fauna, ranging from invertebrates to humans. Many of the
concepts introduced in the consensus statement from the
Wingspread Conference in 1991 by Dr Theo Colborn (Colborn
and Clement, 1992) and the other workshop participants are
now generally accepted by the scientific community which in
turn has improved our understanding of how ‘‘upstream,’’
cellular and molecular alterations in toxicity pathways produce
adverse effects ‘‘downstream’’ at higher dose levels and how

exposure to EDCs during critical developmental periods can
result in adverse effects later in life. Although much has been
learned, the field is relatively new, and many relevant and
timely questions remain. Some of the important areas of
emphasis in the field are presented in Table 4 ‘‘Where do we go
from here?’’. The continued introduction of novel chemicals
(drugs, toxic substances, pesticides, nanomaterials, etc.) into
the environment requires ongoing research and monitoring to
ensure the safeguarding of the environment for generations to
come.
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